✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 利西拉来

利西拉来

CAS 320367-13-3C215H347N61O65SMW 4858

本页收录 利西拉来,CAS 登记号为 320367-13-3,分子式 C215H347N61O65S,分子量 4858,归类于有机化学品。作为主营产品之一,济南圣和化工有限公司 可提供从公斤级到吨级的稳定供货,随货附 COA 与质检资料。

产品概览

CAS号320367-13-3
分子式C215H347N61O65S
分子量4858
LogP-30.8
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

应用领域

有机化学品

利西拉来主要应用于有机化学品。具体使用工况下的添加量与规格要求,欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
运输常规化工运输
样品可协商提供
交期现货/按订单安排

供货能力:利西拉来 备有现货,包装形式为按订单/批次确认(不公开发布)。我们支持对公转账并开具增值税发票,山东省内可安排快速配送,省外按物流时效发货,具体请联系 info@591daili.com。

质量与文件

每批产品随货提供 COA(分析证书);可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

作为化工原料供应服务商,济南圣和化工有限公司 长期服务于化工贸易、食品添加、医药中间体、日化原料等行业的采购需求。除 利西拉来 外,您还可以在站内按 CAS 号或产品分类检索更多品类,获取规格与报价。

常见问题

利西拉来 的 CAS 号是多少?

利西拉来 的 CAS 号为 320367-13-3。

该产品的纯度和包装规格是什么?

常规纯度规格为 按批次COA提供(不公开发布),包装为 按订单/批次确认(不公开发布),随货提供 COA。

利西拉来 有什么用途?

主要应用于有机化学品。

如何购买或获取报价?

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系,注明产品名称、CAS 号与需求数量,一个工作日内回复报价。供应商:济南圣和化工有限公司。

PubChem 公开数据

Description

Lixisenatide · CAS 320367-13-3 · C215H347N61O65S. UNII 74O62BB01U.

Identification

CAS Registry Number320367-13-3
PubChem CID90472060
Molecular formulaC215H347N61O65S
UNII (FDA)74O62BB01U

Computed Descriptors

Molecular Weight4858
XLogP3-30.8
Hydrogen Bond Donor Count70
Hydrogen Bond Acceptor Count77
Rotatable Bond Count170
Exact Mass4857.5510314
Monoisotopic Mass4855.5443218
Topological Polar Surface Area2090
Heavy Atom Count342
Formal Charge0

GHS Hazard Classification

Reported hazard statementsH318 (100%), H361 (100%)

H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Documented Uses

  • Lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type II diabetes mellitus. It is also available in combination with [insulin glargine] for the same indication.
  • Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.
  • Breast Feeding; Lactation; Milk, Human; Hypoglycemic Agents; Incretins; Glucagon-Like Peptide-1 Agonists; GLP-1 Agonists
  • Take at the same time every day.
  • Take before a meal. Take lixisenatide within one hour before the first meal of the day.
  • Established Pharmacologic Class [EPC] - GLP-1 Receptor Agonist

Synonyms

Lixisenatide; Adlyxin; Lyxumia; ZP10A peptide; 320367-13-3; ZP 10; AVE0010; AQVE-10010; AVE 0010; lixisenatida; lixisenatidum; AVE 010; AVE-010; ZP-10; AVE-0010; Des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide

Frequently Asked Questions

What are the CAS number and molecular formula of Lixisenatide?

CAS 320367-13-3; molecular formula C215H347N61O65S; molecular weight — g/mol.

What other names is Lixisenatide known by?

Lixisenatide, Adlyxin, Lyxumia, ZP10A peptide, 320367-13-3, ZP 10.

Is Lixisenatide classified as hazardous?

Hazard statements reported: H318, H361.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

English page: Lixisenatide

鲁ICP备19031700号-2